Valuation BML, Inc. OTC Markets

Stocks

Market Closed - OTC Markets 14:35:26 2026-02-12 EST			5-day change	1st Jan Change
25.21 ^USD	+4.59%		-.--%	+0.99%

08-07	BML, Inc. Provides Dividend Guidance for the Second Quarter End and Year End of Fiscal Year Ending March 31, 2027	CI
08-07	Bml, Inc. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	124,107	120,926	113,405	117,800	151,621	135,878	-	-
Change	-	-2.56%	-6.22%	3.88%	28.71%	-10.38%	-	-
Enterprise Value (EV)	35,311	38,555	44,556	55,527	88,408	135,878	135,878	135,878
Change	-	9.19%	15.56%	24.62%	59.22%	53.69%	0%	0%
P/E	3.71x	7.79x	18.8x	18.8x	19.9x	18x	15.7x	13x
PBR	1.06x	0.98x	0.9x	0.91x	1.19x	1.04x	1.01x	0.97x
PEG	-	-0.1x	-0.3x	5.01x	0.7x	-14.15x	1.1x	0.6x
Capitalization / Revenue	0.67x	0.76x	0.82x	0.82x	1.01x	0.88x	0.85x	0.82x
EV / Revenue	0x	0x	0x	0x	0x	0.88x	0.85x	0.82x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	12.4x	11x	9.57x
EV / FCF	0x	0x	-0x	-0x	0x	33.9x	13.9x	12.1x
FCF Yield	30.9%	3.4%	-5.9%	-0.84%	8.59%	2.95%	7.17%	8.28%
Dividend per Share ²	120	100	80	120	125	125	140	170
Rate of return	3.88%	3.24%	2.75%	3.97%	3.09%	3.45%	3.86%	4.69%
EPS ²	833.2	395.8	154.8	160.6	203.5	201	230.9	277.8
Distribution rate	14.4%	25.3%	51.7%	74.7%	61.4%	62.2%	60.6%	61.2%
Net sales ¹	186,067	159,462	137,964	143,191	150,262	155,100	160,200	165,300
EBITDA	54,690	30,193	15,867	-	-	-	-	-
EBIT ¹	48,889	23,936	9,167	9,364	10,421	11,000	12,300	14,200
Net income ¹	33,741	15,578	6,034	6,263	7,748	7,400	8,200	9,500
Net Debt	-88,796	-82,371	-68,849	-62,273	-63,213	-	-	-
Reference price ²	3,090.00	3,085.00	2,909.00	3,020.00	4,045.00	3,625.00	3,625.00	3,625.00
Nbr of stocks (in thousands)	40,164	39,198	38,984	39,007	37,484	37,484	-	-
Announcement Date	5/13/22	5/12/23	5/10/24	5/9/25	5/13/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NATERA, INC.	-242.23x	16.11x	-288.72x	-.--%	47.86B
LABCORP HOLDINGS INC.	24.45x	2.2x	12.61x	0.86%	27.28B
SONIC HEALTHCARE LIMITED	17.19x	1.33x	7.55x	5.09%	7.47B
RADNET, INC.	1097.43x	-	-	-	6.05B
DR. LAL PATHLABS LIMITED	50.91x	9.42x	32.44x	0.98%	3.31B
GENEDX HOLDINGS CORP.	-25.95x	-	-	-	2.6B
NEOGENOMICS, INC.	-56.87x	-	-	-.--%	2.18B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	38.24x	1.96x	14.99x	1.34%	2.16B
FLEURY S.A.	14.15x	1.44x	5.65x	4.95%	1.97B
Average	101.92x	5.41x	-35.91x	1.89%	11.21B
Weighted average by Cap.	-40.41x	9.76x	-147.35x	0.84%